Menu Search
Equities

Biote Corp

BTMD:NMQ

Biote Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)5.56
  • Today's Change-0.09 / -1.59%
  • Shares traded96.76k
  • 1 Year change+25.51%
  • Beta0.9670
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Biote Corp grew revenues 12.37% from 164.96m to 185.36m. In addition the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as a percent of sales). The company reported positive net income, improving from a loss of 969.00k to a profit of 3.32m.
Gross margin69.65%
Net profit margin8.24%
Operating margin15.90%
Return on assets13.31%
Return on equity--
Return on investment16.33%
More ▼

Cash flow in USDView more

In 2023, Biote Corp increased its cash reserves by 12.33%, or 9.77m. The company earned 26.88m from its operations for a Cash Flow Margin of 14.50%. In addition the company used 2.71m on investing activities and also paid 14.38m in financing cash flows.
Cash flow per share0.5643
Price/Cash flow per share16.09
Book value per share-4.62
Tangible book value per share-5.15
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 207.28%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		147.34
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.